However, GnRH-a (agonistic analog) treatment for 2 days in hyperstimulated rats produces a decrease in VEGF expression and that of its receptor (VEGFR), preventing ovarian hyperstimulation syndrome.[26]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.